Last reviewed · How we verify
cipralex
At a glance
| Generic name | cipralex |
|---|---|
| Also known as | Escitalopram, Chemical/Pharmaceutical alternative name: Escitalopram |
| Sponsor | RWTH Aachen University |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Dynamic Networks in Depression Treatment: Mechanisms of Change in Pharmacological, Psychological and Combined Treatment of Depression (PHASE4)
- TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children (PHASE4)
- Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder (NA)
- Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease (PHASE2)
- Acupuncture and Escitalopram for Treating Major Depression Clinical Study (NA)
- Pattern Separation in Major Depressive Disorder (PHASE1)
- Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D) (PHASE4)
- Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |